ZIC2 and prostate carcinoma: In mouse models, the knockdown of MTF1 and the knockout of ZIC2 significantly inhibited tumor growth of cadmium-transformed BPH1 (CTBPH1) cells, suggesting a potential therapeutic strategy for prostate cancer.